Abstract
Objectives
Cell-based therapies for bone augmentation after tooth loss and for the treatment of periodontal defects improve healing defects. Usually, osteogenic cells or stem cells are cultivated in 2D primary cultures, before they are combined with scaffold materials, even though this means a loss of the endogenous 3D microenvironment for the cells. Moreover, the use of single-cell suspensions for the inoculation of scaffolds or for the direct application into an area of interest has the disadvantages of low initial cell numbers and susceptibility to unwanted cellular distribution, respectively.
Materials and methods
We addressed the question whether an alternative to monolayer cultures, namely 3D microtissues, has the potential to improve osteogenic tissue engineering and its clinical outcome.
Results
By contrast, to monolayer cultures, osteogenic differentiation of 3D microtissues is enhanced by mimicking in vivo conditions. It seems that the osteogenic differentiation in microtissues is enhanced by strong integrin–extracellular matrix interaction and by stronger autocrine BMP2 signaling. Moreover, microtissues are less prone to wash out by body fluids and allow the precise administration of large cell numbers.
Conclusion
Microtissue cultures have closer characteristics with cells in vivo and their enhanced osteogenic differentiation makes scaffold-free microtissues a promising concept in osteogenic tissue engineering.
Clinical relevance
Microtissues are particularly suitable for tissue engineering because they improve seeding efficiency of biomaterials by increasing the cell load of a scaffold. This results in accelerated osteogenic tissue formation and could contribute to earlier implant stability in mandibular bone augmentation.
Similar content being viewed by others
References
Sasso RC, LeHuec JC, Shaffrey C (2005) Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech 18(Suppl):S77–S81
Meyer U, Wiesmann HP, Berr K, Kubler NR, Handschel J (2006) Cell-based bone reconstruction therapies—principles of clinical approaches. Int J Oral Maxillofac Implants 21(6):899–906
Petite H, Vandamme K, Monfoulet L, Logeart-Avramoglou D (2011) Strategies for improving the efficacy of bioengineered bone constructs: a perspective. Osteoporos Int 22(6):2017–2021
Zhang ZY, Teoh SH, Hui JH, Fisk NM, Choolani M, Chan JK (2012) The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials 33(9):2656–2672
Zhang Z (2011) Bone regeneration by stem cell and tissue engineering in oral and maxillofacial region. Front Med 5(4):401–413
Abbott A (2003) Cell culture: biology’s new dimension. Nat 424(6951):870–872
Burns JS, Rasmussen PL, Larsen KH, Schroder HD, Kassem M (2010) Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential. Tissue Eng Part A 16(7):2331–2342
Muraglia A, Corsi A, Riminucci M, Mastrogiacomo M, Cancedda R, Bianco P, Quarto R (2003) Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci 116(Pt 14):2949–2955
Trojani C, Weiss P, Michiels JF, Vinatier C, Guicheux J, Daculsi G, Gaudray P, Carle GF, Rochet N (2005) Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydroxypropylmethylcellulose hydrogel. Biomaterials 26(27):5509–5517
Boehrs J, Zaharias RS, Laffoon J, Ko YJ, Schneider GB (2008) Three-dimensional culture environments enhance osteoblast differentiation. J Prosthodont 17(7):517–521
Kale S, Biermann S, Edwards C, Tarnowski C, Morris M, Long MW (2000) Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 18(9):954–958
Tortelli F, Cancedda R (2009) Three-dimensional cultures of osteogenic and chondrogenic cells: a tissue engineering approach to mimic bone and cartilage in vitro. Eur Cell Mater 17:1–14
Kunz-Schughart LA, Kreutz M, Knuechel R (1998) Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int J Exp Pathol 79(1):1–23
Meyer U, Wiesmann HP, Libera J, Depprich R, Naujoks C, Handschel J (2012) Cartilage defect regeneration by ex vivo engineered autologous microtissue—preliminary results. Vivo 26(2):251–257
Arufe MC, De la Fuente A, Mateos J, Fuentes I, De Toro FJ, Blanco FJ (2011) Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev 20(7):1199–1212
Estes BT, Diekman BO, Gimble JM, Guilak F (2010) Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 5(7):1294–1311
Kafienah W, Al-Fayez F, Hollander AP, Barker MD (2003) Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach. Arthritis Rheum 48(3):709–718
Keller GM (1995) In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7(6):862–869
Potter SW, Morris JE (1985) Development of mouse embryos in hanging drop culture. Anat Rec 211(1):48–56
Wobus AM, Wolf E, Beier HM (2000) Embryonic stem cells and nuclear transfer strategies. Present state and future prospects. Cells Tissues Organs 166(1):1–5
Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83(2):173–180
Handschel J, Naujoks C, Langenbach F, Berr K, Depprich RA, Ommerborn MA, Kubler NR, Brinkmann M, Kogler G, Meyer U (2010) Comparison of ectopic bone formation of embryonic stem cells and cord blood stem cells in vivo. Tissue Eng Part A 16(8):2475–2483
Langenbach F, Berr K, Naujoks C, Hassel A, Hentschel M, Depprich R, Kubler NR, Meyer U, Wiesmann H-P, Kogler G, Handschel J (2011) Generation and differentiation of microtissues from multipotent precursor cells for use in tissue engineering. Nat Protocols 6(11):1726–1735
Hildebrandt C, Buth H, Thielecke H (2011) A scaffold-free in vitro model for osteogenesis of human mesenchymal stem cells. Tissue Cell 43(2):91–100
Langenbach F, Naujoks C, Laser A, Kelz M, Kersten-Thiele P, Berr K, Depprich R, Kubler N, Kogler G, Handschel J (2012) Improvement of the cell-loading efficiency of biomaterials by inoculation with stem cell-based microspheres, in osteogenesis. J Biomater Appl 26(5):549–564
Handschel JG, Depprich RA, Kubler NR, Wiesmann HP, Ommerborn M, Meyer U (2007) Prospects of micromass culture technology in tissue engineering. Head Face Med 3:4
Cukierman E, Pankov R, Stevens DR, Yamada KM (2001) Taking cell–matrix adhesions to the third dimension. Sci 294(5547):1708–1712
Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137(1):231–245
Sivaraman A, Leach JK, Townsend S, Iida T, Hogan BJ, Stolz DB, Fry R, Samson LD, Tannenbaum SR, Griffith LG (2005) A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6(6):569–591
Stevens MM, George JH (2005) Exploring and engineering the cell surface interface. Sci 310(5751):1135–1138
Kelm JM, Fussenegger M (2004) Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 22(4):195–202
Garcia AJ (2005) Get a grip: integrins in cell–biomaterial interactions. Biomaterials 26(36):7525–7529
Heino J, Huhtala M, Kapyla J, Johnson MS (2009) Evolution of collagen-based adhesion systems. Int J Biochem Cell Biol 41(2):341–348
Barczyk M, Carracedo S, Gullberg D (2010) Integrins. Cell Tissue Res 339(1):269–280
Biggs MJ, Dalby MJ (2010) Focal adhesions in osteoneogenesis. Proc Inst Mech Eng H 224(12):1441–1453
Lim JY, Dreiss AD, Zhou Z, Hansen JC, Siedlecki CA, Hengstebeck RW, Cheng J, Winograd N, Donahue HJ (2007) The regulation of integrin-mediated osteoblast focal adhesion and focal adhesion kinase expression by nanoscale topography. Biomaterials 28(10):1787–1797
Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280(39):33132–33140
Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309(5737):1074–1078
Hong D, Chen HX, Xue Y, Li DM, Wan XC, Ge R, Li JC (2009) Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol 116(1–2):86–92
Phillips JE, Gersbach CA, Wojtowicz AM, Garcia AJ (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119(Pt 3):581–591
Franceschi RT, Iyer BS (1992) Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7(2):235–246
Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT (2002) Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17(1):101–110
Kundu AK, Khatiwala CB, Putnam AJ (2009) Extracellular matrix remodeling, integrin expression, and downstream signaling pathways influence the osteogenic differentiation of mesenchymal stem cells on poly(lactide-co-glycolide) substrates. Tissue Eng Part A 15(2):273–283
Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (2009) Phosphate regulates osteopontin gene transcription. J Dent Res 88(1):39–44
Tada H, Nemoto E, Foster BL, Somerman MJ, Shimauchi H (2011) Phosphate increases bone morphogenetic protein-2 expression through cAMP-dependent protein kinase and ERK1/2 pathways in human dental pulp cells. Bone 48(6):1409–1416
Afzal F, Pratap J, Ito K, Ito Y, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Javed A (2005) Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol 204(1):63–72
Payne KA, Meszaros LB, Phillippi JA, Huard J (2010) Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells. Tissue Eng Part A 16(12):3647–3655
Ito T, Sawada R, Fujiwara Y, Tsuchiya T (2008) FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology 56(1):1–7
Maehata Y, Takamizawa S, Ozawa S, Kato Y, Sato S, Kubota E, Hata R (2006) Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Matrix Biol 25(1):47–58
Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R, van Rijn L, Gaspar C, Fodde R, Janssen F, van Blitterswijk C, de Boer J (2008) cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A 105(20):7281–7286
Salasznyk RM, Williams WA, Boskey A, Batorsky A, Plopper GE (2004) Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 2004(1):24–34
Levi B, Nelson ER, Brown K, James AW, Xu D, Dunlevie R, Wu JC, Lee M, Wu B, Commons GW, Vistnes D, Longaker MT (2011) Differences in osteogenic differentiation of adipose-derived stromal cells from murine, canine, and human sources in vitro and in vivo. Plast Reconstr Surg 128(2):373–386
Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q, Shi Q, Zhang BQ, Wagner ER, Rastegar F, Kim SH, Jiang W, Shen J, Huang E, Gao Y, Gao JL, Zhou JZ, Luo J, Huang J, Luo X, Bi Y, Su Y, Yang K, Liu H, Luu HH, Haydon RC, He TC, He BC (2010) Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 5(7):e11917
Langenbach F, Naujoks C, Kersten-Thiele PV, Berr K, Depprich RA, Kubler NR, Kogler G, Handschel J (2010) Osteogenic differentiation influences stem cell migration out of scaffold-free microspheres. Tissue Eng Part A 16(2):759–766
Lammers L, Naujoks C, Berr K, Depprich R, Kubler N, Meyer U, Langenbach F, Luttenberg B, Kogler G, Wiesmann HP, Handschel J (2012) Impact of DAG stimulation on mineral synthesis, mineral structure and osteogenic differentiation of human cord blood stem cells. Stem Cell Res 8(2):193–205
Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J (1991) Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J 274(Pt 2):513–520
Wang W, Itaka K, Ohba S, Nishiyama N, Chung UI, Yamasaki Y, Kataoka K (2009) 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 30(14):2705–2715
Legros R, Balmain N, Bonel G (1987) Age-related changes in mineral of rat and bovine cortical bone. Calcif Tissue Int 41(3):137–144
Leong L, Hughes PE, Schwartz MA, Ginsberg MH, Shattil SJ (1995) Integrin signaling: roles for the cytoplasmic tails of alpha IIb beta 3 in the tyrosine phosphorylation of pp 125FAK. J Cell Sci 108(Pt 12):3817–3825
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5):747–754
Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT (1998) Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 273(49):32988–32994
Franceschi RT, Iyer BS, Cui Y (1994) Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res Off J Am Soc Bone Miner Res 9(6):843–854
Naujoks C, Langenbach F, Berr K, Depprich R, Kubler N, Meyer U, Handschel J, Kogler G (2011) Biocompatibility of osteogenic predifferentiated human cord blood stem cells with biomaterials and the influence of the biomaterial on the process of differentiation. J Biomater Appl 25(5):497–512
Holy CE, Shoichet MS, Davies JE (2000) Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding density and culture period. J Biomed Mater Res 51(3):376–382
Bitar M, Brown RA, Salih V, Kidane AG, Knowles JC, Nazhat SN (2008) Effect of cell density on osteoblastic differentiation and matrix degradation of biomimetic dense collagen scaffolds. Biomacromolecules 9(1):129–135
Jahn K, Richards RG, Archer CW, Stoddart MJ (2010) Pellet culture model for human primary osteoblasts. Eur Cell Mater 20:149–161
Kabiri M, Kul B, Lott WB, Futrega K, Ghanavi P, Upton Z, Doran MR (2012) 3D mesenchymal stem/stromal cell osteogenesis and autocrine signalling. Biochem Biophys Res Commun 419(2):142–147
Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT (2006) BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res 21(4):637–646
Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC (2000) Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15(4):663–673
Robey PG (2011) Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). Tissue Eng Part B Rev 17(6):423–430
Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131(2):324–336
Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2(4):313–319
Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40(6):1434–1446
Kelm JM, Breitbach M, Fischer G, Odermatt B, Agarkova I, Fleischmann BK, Hoerstrup SP (2012) 3D microtissue formation of undifferentiated bone marrow mesenchymal stem cells leads to elevated apoptosis. Tissue engineering Part A 18(7–8):692–702
Altmann B, Steinberg T, Giselbrecht S, Gottwald E, Tomakidi P, Bächle-Haas M, Kohal RJ (2011) Promotion of osteoblast differentiation in 3D biomaterial micro-chip arrays comprising fibronectin-coated poly(methyl methacrylate) polycarbonate. Biomaterials 32(34):8947–8956
Ferrera D, Poggi S, Biassoni C, Dickson GR, Astigiano S, Barbieri O, Favre A, Franzi AT, Strangio A, Federici A, Manduca P (2002) Three-dimensional cultures of normal human osteoblasts: proliferation and differentiation potential in vitro and upon ectopic implantation in nude mice. Bone 30(5):718–725
Kelm JM, Lorber V, Snedeker JG, Schmidt D, Broggini-Tenzer A, Weisstanner M, Odermatt B, Mol A, Zund G, Hoerstrup SP (2010) A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol 148(1):46–55
Kelm JM, Fussenegger M (2010) Scaffold-free cell delivery for use in regenerative medicine. Adv Drug Deliv Rev 62(7–8):753–764
Berahim Z, Moharamzadeh K, Rawlinson A, Jowett AK (2011) Biologic interaction of three-dimensional periodontal fibroblast spheroids with collagen-based and synthetic membranes. J Periodontol 82(5):790–797
Acknowledgments
This review was supported in part by the Deutsche Forschungsgemeinschaft (DFG) grant HA 3228/3-1.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Langenbach, F., Naujoks, C., Smeets, R. et al. Scaffold-free microtissues: differences from monolayer cultures and their potential in bone tissue engineering. Clin Oral Invest 17, 9–17 (2013). https://doi.org/10.1007/s00784-012-0763-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-012-0763-8